Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05477277 · ClinicalTrials.gov registry record · NA

Adverse Outcomes and Mortality in Liver Transplant

A NA study of Cirrhosis and Sarcopenia, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05477277 is a NA study of Cirrhosis and Sarcopenia that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 100 participants, below the 90,407-participant average among 53 other Cirrhosis trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05477277, a NA study of Cirrhosis and Sarcopenia, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

Prospective natural history pilot study to explore the link between muscle composition using an MRI-based Muscle Assessment Score (MAsS) and adverse outcomes in liver transplant candidates.

Interventions

  • DIAGNOSTIC_TEST MAsS

Study Locations (1)

Arizona

  • Mayo Clinic Arizona - Phoenix

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2022-11-02
Est. Completion 2027-07-01
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT05477277

The ClinicalTrials.gov registry entry for NCT05477277 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 90,407-participant average among 53 other Cirrhosis trials with a reported enrollment target (100% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Cirrhosis appearing as the primary indexed condition, and to 1 intervention - of which MAsS is the first listed.

NCT05477277 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT05477277 about?

NCT05477277 is a clinical study titled "Adverse Outcomes and Mortality in Liver Transplant". Prospective natural history pilot study to explore the link between muscle composition using an MRI-based Muscle Assessment Score (MAsS) and adverse outcomes in liver transplant candidates.

What is the current status of trial NCT05477277?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2022-11-02. Estimated completion is 2027-07-01.

What conditions does trial NCT05477277 study?

This clinical trial studies the following conditions: Cirrhosis, Sarcopenia, End Stage Liver DIsease, Sarcopenic Obesity.

What interventions are being tested in trial NCT05477277?

The interventions under investigation include: MAsS (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05477277?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05477277 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cirrhosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.